Geron Corporation

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Geron Corporation - overview

Established

1992

Location

Foster City, CA, US

Primary Industry

Biotechnology

About

Founded in 1992 by Alex Barkas and Michael D West, and based in California, US, Geron Corporation is a biotechnology company that develops and provides telomerase and telomere biology-based cancer-inhibiting drugs such as the Imetelstat in hematologic myeloid malignancies. In March 2024, a consortium comprised of OrbiMed Advisors, Farallon Capital Management, Boxer Capital, Vivo Capital, Deep Track Capital, and RA Capital Management acquired 42 million shares in Geron Corporation at USD 3 apiece, for approximately USD 150 million. Geron is a biopharmaceutical company focused on developing therapies for blood cancers using a novel approach targeting telomerase, an enzyme involved in the uncontrolled proliferation of malignant cells. Their lead product, a telomerase inhibitor, is used for treating adults with low-to-intermediate-1 risk myelodysplastic syndromes who require frequent red blood cell transfusions and have not responded to other treatments.


Current Investors

OrbiMed Advisors, Vivo Capital, RA Capital Management

Primary Industry

Biotechnology

Sub Industries

Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development

Website

www.geron.com

Verticals

Manufacturing

Company Stage

Mature

Total Amount Raised

Subscriber access only

Geron Corporation - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Private DebtAnnouncedGeron Corporation-
PIPECompletedGeron Corporation-
Private DebtCompletedGeron Corporation-

Displaying 1 - 3 of 3

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.